Neuberger Berman Group LLC Takeda Pharmaceutical CO LTD Transaction History
Neuberger Berman Group LLC
- $130 Billion
- Q3 2025
A detailed history of Neuberger Berman Group LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Neuberger Berman Group LLC holds 48,454 shares of TAK stock, worth $692,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,454
Previous 34,242
41.5%
Holding current value
$692,407
Previous $529,000
34.03%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TAK
# of Institutions
382Shares Held
80.7MCall Options Held
1.67MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...